Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Prospective Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites

NCT03963947 is registered in ClinicalTrials.gov with Alfons Malet i Casajuana as lead sponsor.

NCT NCT03963947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03963947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Prospective Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With House Dust Mites
Lead sponsor
Alfons Malet i Casajuana
Phase
Observational
Overall status
Completed
Start date
June 1, 2019
Completion date
May 24, 2023
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoconjunctivitis with or without allergic asthma